Home - CVMD - NAFLD/NASH


PriMed Non-human Primate Model of Nonalcoholic Fatty Liver Disease (NAFLD/NASH)


Spontaneously obese and dysmetabolic NHPs develop hepatic pathology with characteristics of NAFLD/NASH. The NHP model, permitting both repeated liver biopsies and multiple imaging studies, provides new opportunities to understand the pathogenesis as well as to examine in detail (with sequential repeated liver biopsies and longitudinal metabolic biomarkers) both the progression of the disease and its response to new therapeutic agents.


Using our unique spontaneously obese and dysmetabolic NHPs we developed ultrasonography and Dual Energy CT methods for noninvasive measurement of hepatic steatosis and other pathologic changes in correlation with multiple metabolic disorders and liver fibrosis biomarkers.


PriMed Shines NAFLD/NASH NHP Capability

 Breeding center: n=~3000 rhesus macaques (macaca mulatta)


 Set up 70 NAFLD/NASH rhesus macaques database.


 Advanced imaging technology for all disease models


 Extensive Siemens SOMATOM Definition Flash Dual Energy CT and GE Echo experience for monkey liver fat content quantification.


 Ultrasound-guided Biopsy


  Senior consultant has 30+ years of experience in pathology (ACVP from1989)

 Targets of GLP-1 and FXR have been validated with our models.



         



         



  


  

            


PriMed Posters and Publications


2017 Keystone Symposium on Bile Acid Receptors as Signal Integrators in Liver and Metabolism, Monterey 

Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Nonhuman Primates (NHP’s) is Comparable to Humans for Metabolic Features, Histology and Imaging


Experimental Biology 2017

Diagnosis of Naturally-occurring Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Rhesus Monkeys using dual-energy CT (DECT) and Histopathology Criteria


APASL 2017, Shanghai

1652: Pathological Study of Non-alcoholic Steatohepatitis (NASH) in Rhesus Monkeys

1663:  A Novel FXR Agonist (HT03) for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Rhesus Monkeys with NASH: Evaluation by Dual-energy CT (DECT) and Histopathology



ICO 2016, Vancouver

Diagnosis Of Naturally-occurring Non-alcoholic Steatohepatitis (NASH) In Obese Rhesus Monkeys Using Histopathology Criteria

Quantification Of Hepatic Fat In Naturally-occurring Nonalcoholic Fatty Liver Disease (NAFLD) In Obese Rhesus Monkeys Using Dual-energy CT (DECT)


More information about posterand publications                                                   


Contact Us Right Now



Email : bd@scprimed.com

Tel : +86-28-85921823

Fax : +86-28-62491302

Zip code : 610041

Address : Floor 5, Incubator B4,Tianfu Life & Science Park, No. 88 Southern Keyuan Road,High-tech Zone, Chengdu, Sichuan, China, 610041


Private Plicy